U.S. flag

An official website of the United States government

NM_000530.8(MPZ):c.499G>A (p.Gly167Arg) AND Charcot-Marie-Tooth disease, type I

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Dec 24, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001053594.14

Allele description [Variation Report for NM_000530.8(MPZ):c.499G>A (p.Gly167Arg)]

NM_000530.8(MPZ):c.499G>A (p.Gly167Arg)

Gene:
MPZ:myelin protein zero [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1q23.3
Genomic location:
Preferred name:
NM_000530.8(MPZ):c.499G>A (p.Gly167Arg)
HGVS:
  • NC_000001.11:g.161306414C>T
  • NG_008055.1:g.8559G>A
  • NM_000530.8:c.499G>AMANE SELECT
  • NM_001315491.2:c.499G>A
  • NP_000521.2:p.Gly167Arg
  • NP_001302420.1:p.Gly167Arg
  • LRG_256t1:c.499G>A
  • LRG_256:g.8559G>A
  • LRG_256p1:p.Gly167Arg
  • NC_000001.10:g.161276204C>T
  • NM_000530.6:c.499G>A
  • P25189:p.Gly167Arg
Protein change:
G167R
Links:
UniProtKB: P25189#VAR_004544; dbSNP: rs121913586
Molecular consequence:
  • NM_000530.8:c.499G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001315491.2:c.499G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Charcot-Marie-Tooth disease, type I (CMT1)
Synonyms:
Charcot-Marie-Tooth, Type 1; Charcot-Marie-Tooth disease type 1
Identifiers:
MONDO: MONDO:0019011; MedGen: C0751036

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001217864Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Dec 24, 2021)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

De novo mutation of the myelin P0 gene in Dejerine-Sottas disease (hereditary motor and sensory neuropathy type III).

Hayasaka K, Himoro M, Sawaishi Y, Nanao K, Takahashi T, Takada G, Nicholson GA, Ouvrier RA, Tachi N.

Nat Genet. 1993 Nov;5(3):266-8.

PubMed [citation]
PMID:
7506095

Germline mosaicism of MPZ gene in Dejerine-Sottas syndrome (HMSN III) associated with hereditary stomatocytosis.

Takashima H, Nakagawa M, Kanzaki A, Yawata Y, Horikiri T, Matsuzaki T, Suehara M, Izumo S, Osame M.

Neuromuscul Disord. 1999 Jun;9(4):232-8.

PubMed [citation]
PMID:
10399750
See all PubMed Citations (5)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001217864.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 167 of the MPZ protein (p.Gly167Arg). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with Dejerine-Sottas disease (PMID: 7506095, 10399750, 12242557). In at least one individual the variant was observed to be de novo. This variant is also known as p.Gly138Arg. ClinVar contains an entry for this variant (Variation ID: 208149). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). Experimental studies have shown that this missense change affects MPZ function (PMID: 29687021). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 4, 2026

Modify your search Search (all fields optional) Clear all
Advanced Search